Subscribe

Snapshot

DOI:

Looking at valves with EuroIntervention

With PCR Tokyo Valves in the news, and PCR London Valves still fresh in our minds, what better moment to consider the latest developments in this field, many of which will certainly be topics of conversation at spring meetings, like EuroPCR 2024. Take a look now as we explore the latest tools, emerging data, promising trial designs, along with an expert review of some increasingly used procedures.

EuroIntervention expert review on indications for transcatheter edge-to-edge repair

In an expert review, Mony Shuvy and Francesco Maisano explore the expanding horizons in indications for transcatheter edge-to-edge repair. The authors examine the current clinical evidence on outcomes and limitations for transcatheter edge-to-edge repair in diverse patient populations, including those with severe left ventricular dysfunction, complex valve anatomies and congenital heart disease.

Understanding outcomes of transcatheter edge-to-edge repair

Given the unique pathophysiology of atrial functional mitral regurgitation, Tetsu Tanaka, Marcel Weber and colleagues investigate the potential prognostic benefits of transcatheter edge-to-edge repair and how it may be attenuated by an elevated mean mitral valve pressure gradient.

DragonFly transcatheter valve repair system

Jian’an Wang, D. Scott Lim and colleagues help expand the transcatheter edge-to-edge repair armamentarium by establishing evidence for the safety and efficacy of the DragonFly transcatheter valve repair system for the treatment of patients with symptomatic chronic degenerative mitral regurgitation.

Novel transseptal transcatheter mitral valve replacement system

Lauren S. Ranard, Torsten Vahl and colleagues propose a preclinical study evaluating the performance, feasibility, haemodynamics and biocompatibility of the low-profile Saturn valve for transseptal transcatheter mitral valve replacement. 

Volume 20 Number 4
Feb 19, 2024
Volume 20 Number 4
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00003 Feb 19, 2024
Between Scylla and Charybdis in atrial functional mitral regurgitation
Denti P
free

Expert Review

10.4244/EIJ-D-23-00700 Feb 19, 2024
Evolving indications for transcatheter mitral edge-to-edge repair
Shuvy M and Maisano F
free

State-of-the-Art

10.4244/EIJ-D-22-00725 Jan 23, 2023
Mitral valve transcatheter edge-to-edge repair
Hausleiter J et al
free

Research Correspondence

10.4244/EIJ-D-24-00392 Dec 16, 2024
Very long-term outcomes of mitral transcatheter edge-to-edge repair
Bargagna M et al

Editorial

10.4244/EIJ-E-23-00071 Feb 19, 2024
One-year outcomes with a new mitral edge-to-edge repair device: is mitral TEER about to conquer the world?
Praz F and Samim D
free

Editorial

10.4244/EIJ-E-24-00047 Oct 21, 2024
Mitral valve edge-to-edge repair under scrutiny: what can we learn from transoesophageal echocardiographic follow-up?
Hausleiter J and Stolz L
free

Debate

10.4244/EIJ-E-22-00044 Mar 20, 2023
Transcatheter mitral valve replacement will remain a niche therapy: pros and cons
Cohen D et al
free

EXPERT REVIEW

10.4244/EIJ-D-17-00505 Sep 24, 2017
Mitral valve: repair/clips/cinching/chordae
Vahanian A et al
free

10.4244/EIJV15I7A103 Sep 20, 2019
Mitral valve regurgitation: a plea for transcatheter mitral valve replacement
Modine T et al
free
Trending articles
69.996

10.4244/EIJV13I12A217 Dec 8, 2017
Swimming against the tide: insights from the ORBITA trial
Al-Lamee R and Francis D
free
59.65

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
57.6

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
38.75

State-of-the-Art

10.4244/EIJ-D-23-00912 Oct 7, 2024
Optical coherence tomography to guide percutaneous coronary intervention
Almajid F et al
free
15.85

State-of-the-Art

10.4244/EIJ-D-23-01050 Jul 15, 2024
Durability of transcatheter aortic valve implantation
Ternacle J et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
What patient populations does the first study find may benefit from TEER?
How may elevated mean mitral valve pressure gradients impact outcomes according to the second study?
What new TEER device did the third study establish is safe and effective?
What type of study did the last study propose to evaluate the new Saturn mitral valve replacement system?
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved